Ian De Bruin, NHS Consultant and Senior Project Manager in Currie & Brown’s Healthcare Division says: “Lord Darzi’s review creates a new vision for primary care services that puts pressure on estates managers to develop innovative solutions that can facilitate the move from secondary to primary care with built-in flexibility – all within a relatively short timescale.
“Whilst government spending on the NHS estate is probably higher than at any other time, estates managers are entering new territory as they adapt to meet the challenges of cross sector partnerships and co-location of health and other public services and new arrangements for ownership.
“With any redesign of services and facilities the starting point must always be a full assessment of clinical need, however once clinical priorities are identified, these must generate a ‘Strategic fit’ across the Estate. A thorough examination of land and property will benefit the SSDP by identifying costs to raise and maintain Assets to an acceptable standard, whilst highlighting where opportunities for adaptation and disposal lie.
“By addressing these key areas, NHS Boards will develop their property assets in a strategic way that ensures the estate meets the ongoing needs of the new clinical services environment and the staff that deliver those services, whilst balancing the pressures of cost and budget.
Currie & Brown has an extensive track record in the UK healthcare sector, managing large and medium sized development and re-configuration programmes. The Company's healthcare team has an in depth understanding of the clinical process and how the health environment can improve patient care.
Note to Editors:
Currie & Brown is a leading consultant in asset management and construction matters in the healthcare sector. It advises the NHS in the UK across four areas of expertise: Project Management, Cost Management, Consulting and Business Consultancy.
One of the top ten consultancies in the world, Currie & Brown is on national NHS frameworks in England and Scotland and has advised on some of the largest health projects in the UK in recent years.
The business is headquartered in London with 10 regional offices across the UK. It also has offices throughout Europe, Middle East, Asia, Australia, the Americas and associated offices in Africa and employs 1000 worldwide.